SensoMotoric Instruments (SMI) sells Ophthalmic Division to Alcon

      SensoMotoric Instruments (SMI) sells Ophthalmic Division to Alcon

  PR Newswire

  TELTOW, Germany and BOSTON, November 20, 2012

TELTOW, Germany and BOSTON, November 20, 2012 /PRNewswire/ --

SMI sets focus on new applications for their leading ocular technology and
expands leadership in scientific research eye tracking

SensoMotoric Instruments GmbH (SMI), leader in eye tracking, eye control,
guidance and registration technology, sells its Ophthalmic Division to Alcon ,
the global leader in eye care. The acquisition provides Alcon with SMI's
leading ocular surgical guidance technology , such as real-time eye tracking,
automatic registration of ocular imaging, and intraocular lens (IOL)
positioning and alignment guidance, in order to help improve patient outcomes
in cataract surgery. SMI will now fully focus its efforts on the rapidly
growing opportunities with end users and OEM customers in gaze based
interaction , eye tracking applications in other medical areas and to expand
their leadership in scientific eye tracking applications .

Alcon plans to integrate the newly acquired ocular surgical guidance
technology into its existing global cataract portfolio, and leverage its
global leadership in eye care to help bring this advanced technology to
surgeons across the world. Alcon offers the industry's most complete line of
surgical products for cataract surgery, including equipment for cataract
procedures, as well as IOLs to treat cataracts and correct refractive errors,
like presbyopia and astigmatism.

"We are proud and glad to have found in Alcon the best possible business
partner to develop the potential of our team, technology, and products in
cataract surgery", said the former head of the SMI Ophthalmic Division Dr.
Oliver Kersting who continues at Alcon to lead the integration of the SMI
technology into Alcon's cataract product portfolio. "We know and have been
working with Alcon successfully for more than a decade. We have great respect
for Alcon's leadership in Ophthalmology and their ability to bring innovations
to broad market." said Eberhard Schmidt, Managing Director of SMI. "SMI has
been growing very rapidly and faces a dramatically expanding array of
opportunities based on our leading technology platform. Multimodal user
interaction as well as analytical applications provide great opportunities to
bring valuable innovations to scientists, OEM-Partners and end-users that will
benefit from our increased focus in this area going forward."

About SensoMotoric Instruments GmbH (SMI)

SMI ( http://www.smivision.com ) is a world leader in dedicated computer
vision applications, developing and marketing eye & gaze tracking systems and
OEM solutions for a wide range of applications such as marketing,
human-computer-interfaces, ophthalmology, neurology, psychology, ergonomics
and usability. SMI serves customers around the globe from offices in Teltow,
near Berlin, Germany and Boston, USA, backed by a network of trusted local
partners in many countries.

Contact: stefanie.gehrke@smi.de Name: Stefanie Gehrke Titel: Market
Communication Manager Phone : +49(0)3328-3955-00    SensoMotoric
Instruments GmbH Fax  : +49(0)3328-3955-99    Warthest. 21 WEB  :
http://www.smivision.com  14513 Teltow E-Mail : info@smivision.de   
Germany Geschäftsführer / Managing Director: Eberhard Schmidt (Dipl.-Ing.,
MBA) Amtsgericht Potsdam HRB 22447 P; VAT-No.: DE 266508899